DISEASE CONTROL AND CHANGES IN INDIVIDUAL TREATMENT OUTCOMES FROM WEEK 14 TO WEEK 52 WITH VEDOLIZUMAB OR ADALIMUMAB IN ULCERATIVE COLITIS: A VARSITY TRIAL POST HOC ANALYSIS

Stefan Schreiber  1     Silvio Danese  2     Laurent Peyrin-Biroulet  3     Jean-Frederic Colombel  4     Bruce E. Sands  4     Dirk Lindner  5     Richard A. Lirio  6     Christian Agboton  7     Edward V. Loftus Jr.    
1 University Hospital Schleswig-Holstein,Kiel,Germany
2 Humanitas University,Milan,Italy
3 Nancy University Hospital,Nancy,France
4 Icahn School of Medicine at Mount Sinai,New York,United States
5 Takeda,Zurich,Switzerland
6 Takeda,Cambridge,United States
7 Takeda,Zurich,Switze

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing